649 results on '"Rhett P, Ketterling"'
Search Results
2. One thousand patients with essential thrombocythemia: the Mayo Clinic experience
3. Unraveling the genomic underpinnings of unbalanced MYC break-apart FISH results using whole genome sequencing analysis
4. Prognostic impact of SF3B1 mutation and multilineage dysplasia in myelodysplastic syndromes with ring sideroblasts: a Mayo Clinic study of 170 informative cases
5. Prospective evaluation of genome sequencing to compare conventional cytogenetics in acute myeloid leukemia
6. Abnormal karyotype is an independent predictor of inferior survival in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
7. Chronic phase CML with sole P190 (e1a2) BCR::ABL1: long-term outcome among ten consecutive cases
8. Blast phase myeloproliferative neoplasm with prior exposure to ruxolitinib: comparative analysis of mutations and survival
9. Cytogenetic abnormalities in essential thrombocythemia: Clinical and molecular correlates and prognostic relevance in 809 informative cases
10. Myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T): Mayo-Moffitt collaborative study of 158 patients
11. A simple additive staging system for newly diagnosed multiple myeloma
12. Disparity in the detection of chromosome 15 centromere in patients of African ancestry with a plasma cell neoplasm
13. Identification of adult Philadelphia-like acute lymphoblastic leukemia using a FISH‐based algorithm distinguishes prognostic groups and outcomes
14. Adverse karyotype subcategories in acute myeloid leukemia display significant differences in mutation composition and transplant-augmented survival
15. MYC break-apart FISH probe set reveals frequent unbalanced patterns of uncertain significance when evaluating aggressive B-cell lymphoma
16. Daunorubicin-60 versus daunorubicin-90 versus idarubicin-12 for induction chemotherapy in acute myeloid leukemia: a retrospective analysis of the Mayo Clinic experience
17. Mayo Clinic experience with 1123 adults with acute myeloid leukemia
18. CSF3R T618I mutant chronic myelomonocytic leukemia (CMML) defines a proliferative CMML subtype enriched in ASXL1 mutations with adverse outcomes
19. Myeloid malignancies with 5q and 7q deletions are associated with extreme genomic complexity, biallelic TP53 variants, and very poor prognosis
20. SF3B1-mutant myelodysplastic syndrome/myeloproliferative neoplasms: a unique molecular and prognostic entity
21. Impact of acquired del(17p) in multiple myeloma
22. Development of a prognostically relevant cachexia index in primary myelofibrosis using serum albumin and cholesterol levels
23. Targeted next-generation sequencing in blast phase myeloproliferative neoplasms
24. Transdifferentiation of high-grade B-cell lymphoma with MYC and BCL2 rearrangements into histiocytic sarcoma after CAR T-cell therapy: a case report
25. Immunohistochemical Approach to Genetic Subtyping of Anaplastic Large Cell Lymphoma
26. Characterization of unusual <scp>iAMP21</scp> B‐lymphoblastic leukemia ( <scp>iAMP21‐ALL</scp> ) from the Mayo Clinic and Children's Oncology Group
27. Typical, atypical and cryptic t(15;17)(q24;q21) ( PML::RARA ) observed in acute promyelocytic leukemia: A retrospective review of 831 patients with concurrent chromosome and PML::RARA dual‐color dual‐fusion FISH studies
28. <scp>RNAseq</scp> identification of <scp>FISH</scp> ‐cryptic <scp>BCL6</scp> :: <scp>TP63</scp> rearrangement in <scp>ALK</scp> ‐negative anaplastic large‐cell lymphoma
29. Targeted deep sequencing in primary myelofibrosis
30. Targeted deep sequencing in polycythemia vera and essential thrombocythemia
31. Combined Tumors in Hematolymphoid Neoplasms: Case Series of Histiocytic and Langerhans Cell Sarcomas Arising From Low-Grade B-Cell Lymphoma
32. False-negative rates for MYC fluorescence in situ hybridization probes in B-cell neoplasms
33. Clinical correlates, prognostic impact and survival outcomes in chronic myelomonocytic leukemia patients with the JAK2V617F mutation
34. Extramedullary acute myeloid leukemia presenting in young adults demonstrates sensitivity to high-dose anthracycline: a subset analysis from ECOG-ACRIN 1900
35. Inferior survival in high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements is not associated with MYC/IG gene rearrangements
36. Obesity in adult acute myeloid leukemia is not associated with inferior response or survival even when dose capping anthracyclines: An ECOG‐ACRIN analysis
37. Supplementary Table 15 from Integrative Epigenomic Analysis Identifies Biomarkers and Therapeutic Targets in Adult B-Acute Lymphoblastic Leukemia
38. Supplementary Table 4 from Integrative Epigenomic Analysis Identifies Biomarkers and Therapeutic Targets in Adult B-Acute Lymphoblastic Leukemia
39. Supplementary Table 2 from Integrative Epigenomic Analysis Identifies Biomarkers and Therapeutic Targets in Adult B-Acute Lymphoblastic Leukemia
40. Supplementary Tables 1, 3, 5, 8-9, 11-12, 14, Figures 1-14, Methods from Integrative Epigenomic Analysis Identifies Biomarkers and Therapeutic Targets in Adult B-Acute Lymphoblastic Leukemia
41. Supplementary Table 7 from Integrative Epigenomic Analysis Identifies Biomarkers and Therapeutic Targets in Adult B-Acute Lymphoblastic Leukemia
42. Supplementary Table 1 from Rearrangements and Amplification of IER3 (IEX-1) Represent a Novel and Recurrent Molecular Abnormality in Myelodysplastic Syndromes
43. Data from Rearrangements and Amplification of IER3 (IEX-1) Represent a Novel and Recurrent Molecular Abnormality in Myelodysplastic Syndromes
44. <scp> TP53 </scp> mutations and variant allele frequency in myelodysplastic syndromes with del(5q): A <scp>Mayo‐Moffitt</scp> study of 156 informative cases
45. Utilizing next-generation sequencing to characterize a case of acute myeloid leukemia with t(4;12)(q12;p13) in the absence of ETV6/CHIC2 and ETV6/PDGFRA gene fusions
46. Prognostic significance of acquired 1q22 gain in multiple myeloma
47. A rare case of atypical chronic myeloid leukemia associated with t(8;22)(p11.2;q11.2)/ BCR-FGFR1 rearrangement: A case report and literature review
48. Biphenotypic Acute Leukemia versus Myeloid Antigen-Positive ALL: Clinical Relevance of WHO Criteria for Mixed Phenotype Acute Leukemia
49. Recurrent Chromosomal Abnormalities in Tissues Involved by Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
50. Dual Primary IGH Translocations in Multiple Myeloma: A Novel Finding
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.